Excellerant Stock Today
| EXCL Stock | USD 0.0002 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressModerate
|
Excellerant is selling for 2.0E-4 as of the 3rd of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.0E-4. Excellerant has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 5th of November 2025 and ending today, the 3rd of February 2026. Click here to learn more.
Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company was incorporated in 2019 and is based in Brussels, Belgium. Excellerant is traded on OTC Exchange in the United States. The company has 5.65 M outstanding shares. More on Excellerant
Moving against Excellerant Stock
| 1.0 | YMDAF | Yamada Holdings Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Excellerant Stock Highlights
| Business Concentration | Financials, Capital Markets, Shell Companies, Financial Services (View all Sectors) |
Excellerant (EXCL) is traded on OTCCE Exchange in USA and employs 1 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.13 K. Excellerant conducts business under Capital Markets sector and is part of Financials industry. The entity has 5.65 M outstanding shares.
Excellerant generates negative cash flow from operations
Check Excellerant Probability Of Bankruptcy
Ownership AllocationExcellerant retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Excellerant Ownership Details
Excellerant Stock Against Markets
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Excellerant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. For more information on how to buy Excellerant Stock please use our How to buy in Excellerant Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Excellerant. Projected growth potential of Excellerant fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Excellerant assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Excellerant requires distinguishing between market price and book value, where the latter reflects Excellerant's accounting equity. The concept of intrinsic value - what Excellerant's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Excellerant's price substantially above or below its fundamental value.
It's important to distinguish between Excellerant's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Excellerant should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Excellerant's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.